Cariprazine 是一种新型抗精神病候选药物，结合D3、D2和5-HT1A的Ki为0.085、0.49 和 2.6 nM。

Cariprazine is a novel antipsychotic drug candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).

839712-12-8

C21H32Cl2N4O

427.41

RGH-188;卡利拉嗪

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years